Reference Source

Altesse Cosmetique Inc · 66-41 · CANADA

For Altesse Cosmetique Inc · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is BP 452 BR , Montreal, QC CANADA, verified against its source on 2026-09-16.

Firm
Altesse Cosmetique Inc verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CANADA verified
Address
BP 452 BR , Montreal, QC CANADA verified
Date published
09/30/2009 verified
Product code
66 V - - 99 Miscellaneous Patent Medicines, Etc. verified
FDA notes
Capillary Serum with Placenta. The buffalo district recently detained two hair lotions with claims of anti-hair loss. The district detained the products based on violation of 21 CFR 310.527(b) in that the products were represented as external hair loss prevention lotions which is regarded as a new drug within the meaning of section 201(p) for which a new drug application (NDA) under section 505 is required for marketing. The shipments were commercial entries which appeared to be for distribution and sale in the United States. verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Altesse Cosmetique Inc Date Published : 09/30/2009 BP 452 BR , Montreal, QC CANADA 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/30/2009 Notes: Capillary Serum with Placenta. The buffalo district recently detained two hair lotions with claims of anti-hair loss. The district detained the products based on violation of 21 CFR 310.527(b) in that the products were represented as external hair loss prevention lotions which is regarded as a new drug within the meaning of section 201(p) for which a new drug application (NDA) under section 505 is required for marketing. The shipments were commercial entries which appeared to be for distribution and sale in the United States.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.